[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Medical News & Perspectives
April 21, 1999

IOM Committee Gazes Into New Vaccine Future

Author Affiliations

Not Available

Not Available

JAMA. 1999;281(15):1366-1367. doi:10.1001/jama.281.15.1366-JMN0421-3-1

Bethesda, Md—A committee of the Institute of Medicine (IOM) has developed a useful crystal ball for policymakers who have to decide priorities for developing new vaccines, given the available resources. As a way of thinking about different types of vaccines, both preventive and therapeutic, the group estimated the costs and benefits of developing 26 vaccines for managing diseases of domestic importance that were deemed feasible to develop during the next 20 years.

First Page Preview View Large
First page PDF preview
First page PDF preview